Biogen and Eisai to reveal results of Alzheimer's drug trial

2:52 PM ET Wed, 25 July 2018

CNBC's Meg Tirrell reports on the expectations for the Alzheimer's drug trial from Biogen and Japanese drugmaker Eisai.